Cisplatin 50 mg Inj

₹ 335/Vial

CompositionCisplatin 50 mg Inj
ManufactureCelon labs
Dosage50mg
BrandCELPLAT 50
OriginINDIA
AvailabilityIn Stock
View in Hindi सिसप्लैटिन 50 मिलीग्राम इंज
CISPLAT 50MG INJECTION contains a medicine called Cisplatin which is a platinum-based chemotherapeutic agent. It works against abnormal growth and multiplication of cancer cells in the body.
Manufactured ByKHANDELWAL LABORATORIES PVT LTD
Medicine BrandPLATINEX
Medicine FormInjection
Medicine NameCISPLATIN INJECTION BP PLATINEX
Medicine Strength50 mg/50 ml
Packaging Size50 ml
Packaging TypeVial
Salt CompositionCisplatin, Mannitol, Sodium Chloride, Water for Injection

Exports To: United States Of America | United Kingdom | Canada | Saudi Arabia | Egypt

Find products similar to Cisplatin 50 Mg Inj

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNagpur
ShippingAs per delivery location

Product Image

Cisplatin 50 mg Inj-1Cisplatin 50 mg Inj-2Cisplatin 50 mg Inj-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
15-11-2018
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Mar 2023
GST
27AAPFG2746N1ZR
Import Export Code (IEC)
50169*****
Exports to
United States Of America | United Kingdom | Canada | Saudi Arabia | Egypt
Established in the year of 2018. We ”Mymedstores” are a leading Trader - Wholesaler/Distributor of a wide range of Male Organ Developer Pump, Teriparatide Injection etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, we are grateful to Our CEO Ritesh Gajwani whose continual backing and direction have been useful to us for attaining exponential development in the current market